250 related articles for article (PubMed ID: 27174920)
61. EHMT2 methyltransferase governs cell identity in the lung and is required for KRAS
Pribluda A; Daemen A; Lima AN; Wang X; Hafner M; Poon C; Modrusan Z; Katakam AK; Foreman O; Eastham J; Hung J; Haley B; Garcia JT; Jackson EL; Junttila MR
Elife; 2022 Aug; 11():. PubMed ID: 35983994
[TBL] [Abstract][Full Text] [Related]
62. EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression.
Wang J; Xu H; Ge S; Xue C; Li H; Jing X; Liang K; Zhang X; Zhang C
Cancer Biol Med; 2021 Oct; 19(6):836-49. PubMed ID: 34633777
[TBL] [Abstract][Full Text] [Related]
63. Beneficial effects of diazepin-quinazolin-amine derivative (BIX-01294) on preimplantation development and molecular characteristics of cloned mouse embryos.
Huang Y; Jiang X; Yu M; Huang R; Yao J; Li M; Zheng F; Yang X
Reprod Fertil Dev; 2017 Jun; 29(6):1260-1269. PubMed ID: 27477633
[TBL] [Abstract][Full Text] [Related]
64. [Inhibition of G9a attenuates cell proliferation via the mitochondrial apoptosis pathway in lung adenocarcinoma].
Wan HJ; Lyu W; Yu L; Zhou ZY; Hu YJ; Hu J
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):13-17. PubMed ID: 28104027
[No Abstract] [Full Text] [Related]
65. MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis.
Tu WB; Shiah YJ; Lourenco C; Mullen PJ; Dingar D; Redel C; Tamachi A; Ba-Alawi W; Aman A; Al-Awar R; Cescon DW; Haibe-Kains B; Arrowsmith CH; Raught B; Boutros PC; Penn LZ
Cancer Cell; 2018 Oct; 34(4):579-595.e8. PubMed ID: 30300580
[TBL] [Abstract][Full Text] [Related]
66. G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome.
Casciello F; Al-Ejeh F; Miranda M; Kelly G; Baxter E; Windloch K; Gannon F; Lee JS
Theranostics; 2020; 10(10):4515-4529. PubMed ID: 32292512
[No Abstract] [Full Text] [Related]
67. Inhibition of H3K9 methyltransferase G9a induces autophagy and apoptosis in oral squamous cell carcinoma.
Ren A; Qiu Y; Cui H; Fu G
Biochem Biophys Res Commun; 2015 Mar; 459(1):10-7. PubMed ID: 25634693
[TBL] [Abstract][Full Text] [Related]
68. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
[TBL] [Abstract][Full Text] [Related]
69. Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.
Lin X; Huang Y; Zou Y; Chen X; Ma X
Oncol Rep; 2016 May; 35(5):3041-9. PubMed ID: 27081761
[TBL] [Abstract][Full Text] [Related]
70. G9A promotes tumor cell growth and invasion by silencing CASP1 in non-small-cell lung cancer cells.
Huang T; Zhang P; Li W; Zhao T; Zhang Z; Chen S; Yang Y; Feng Y; Li F; Shirley Liu X; Zhang L; Jiang G; Zhang F
Cell Death Dis; 2017 Apr; 8(4):e2726. PubMed ID: 28383547
[TBL] [Abstract][Full Text] [Related]
71. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
[TBL] [Abstract][Full Text] [Related]
72. Euchromatic histone lysine methyltransferase 2 facilitates radioresistance in prostate cancer by repressing endoplasmic reticulum protein 29 transcription.
Huang ZC; Huang J; Huang CK; Hou Y; Zhu B
Kaohsiung J Med Sci; 2023 Jun; 39(6):576-586. PubMed ID: 36825520
[TBL] [Abstract][Full Text] [Related]
73. Inhibition of the H3K9 methyltransferase G9A attenuates oncogenicity and activates the hypoxia signaling pathway.
Ho JC; Abdullah LN; Pang QY; Jha S; Chow EK; Yang H; Kato H; Poellinger L; Ueda J; Lee KL
PLoS One; 2017; 12(11):e0188051. PubMed ID: 29145444
[TBL] [Abstract][Full Text] [Related]
74. G9a-mediated histone methylation regulates cadmium-induced male fertility damage in pubertal mice.
Li M; Liu C; Yang L; Zhang L; Chen C; He M; Lu Y; Feng W; Pi H; Zhang Y; Zhong M; Yu Z; Zhou Z
Toxicol Lett; 2016 Jun; 252():11-21. PubMed ID: 27060504
[TBL] [Abstract][Full Text] [Related]
75. Nanodiamond-Mediated Delivery of a G9a Inhibitor for Hepatocellular Carcinoma Therapy.
Gu M; Toh TB; Hooi L; Lim JJ; Zhang X; Chow EK
ACS Appl Mater Interfaces; 2019 Dec; 11(49):45427-45441. PubMed ID: 31718136
[TBL] [Abstract][Full Text] [Related]
76. Increased expression of EHMT2 associated with H3K9me2 level contributes to the poor prognosis of gastric cancer.
Chen P; Qian Q; Zhu Z; Shen X; Yu S; Yu Z; Sun R; Li Y; Guo D; Fan H
Oncol Lett; 2020 Aug; 20(2):1734-1742. PubMed ID: 32724416
[TBL] [Abstract][Full Text] [Related]
77. Histone methyltransferase G9a modulates hepatic insulin signaling via regulating HMGA1.
Xue W; Huang J; Chen H; Zhang Y; Zhu X; Li J; Zhang W; Yuan Y; Wang Y; Zheng L; Huang K
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):338-346. PubMed ID: 29101051
[TBL] [Abstract][Full Text] [Related]
78. Differential patterns of histone methylase EHMT2 and its catalyzed histone modifications H3K9me1 and H3K9me2 during maturation of central auditory system.
Ebbers L; Runge K; Nothwang HG
Cell Tissue Res; 2016 Aug; 365(2):247-64. PubMed ID: 27083448
[TBL] [Abstract][Full Text] [Related]
79. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM.
Chen MW; Hua KT; Kao HJ; Chi CC; Wei LH; Johansson G; Shiah SG; Chen PS; Jeng YM; Cheng TY; Lai TC; Chang JS; Jan YH; Chien MH; Yang CJ; Huang MS; Hsiao M; Kuo ML
Cancer Res; 2010 Oct; 70(20):7830-40. PubMed ID: 20940408
[TBL] [Abstract][Full Text] [Related]
80. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase.
Kubicek S; O'Sullivan RJ; August EM; Hickey ER; Zhang Q; Teodoro ML; Rea S; Mechtler K; Kowalski JA; Homon CA; Kelly TA; Jenuwein T
Mol Cell; 2007 Feb; 25(3):473-81. PubMed ID: 17289593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]